Full Text View
Tabular View
No Study Results Posted
Related Studies
Abciximab, Clopidogrel and Percutaneous Coronary Intervention in Acute Coronary Syndrome (ISAR-REACT-2)
This study has been completed.
Study NCT00133003   Information provided by Deutsches Herzzentrum Muenchen
First Received: August 18, 2005   Last Updated: April 12, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Disease
Angina, Unstable
Additional conditions recognized in this trial
Acute Coronary Syndrome
Coronary Artery Disease
More general conditions related to this trial
Angina Pectoris
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Chest Pain
Heart Diseases
Myocardial Ischemia
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
Abciximab
Placebo
Additional drug interventions recognized in this trial
Clopidogrel
More general drug interventions related to this trial
Anticoagulants
Hematologic Agents
Pharmacologic Actions
Platelet Aggregation Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Deutsches Herzzentrum Muenchen
Technische Universität München


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services